Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Acquisition costs

Share-based compensation

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Aurora Cannabis

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis products. It also produces and sells indoor cultivation systems and hemp related food products. The firm operates through the Canadian Cannabis and International Cannabis segments. Aurora Cannabis was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. It operates through the Cannabis and Plant Propagation segments. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

NASDAQ | TSX: ACB EDMONTON, AB , Feb. 29, 2024 /PRNewswire/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canada-based leading global medical cannabis company, today announced that it has repaid an aggregate of approximately $7.2 million (US$5.3 million), representing the final payment on the principal amount of its convertible senior notes ("Notes") at a total cash cost of $7.4 million (~US$5.5 million), including accrued interest. Following the completion of this repayment, Aurora's remaining debt1 of $47.9 million relates to Bevo Farms Ltd.

Aurora Completes Final Repayment of Convertible Senior Notes Representing ~$465 Million in Total Repayments Since 2021; Cannabis Operations Are Now Debt Free[1]

NASDAQ | TSX: ACB Partnership will empower UK patients with valuable information and guidance critical to a successful cannabis experience   EDMONTON, AB , Feb. 28, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, today announced the partnership of Aurora Medicine UK Ltd with Script Assist, a cutting-edge medical cannabis prescription platform in the UK. Designed to support UK patients on their journey of well-being, the Script Assist platform provides access to high quality medication through their portal.

Aurora Partners with Script Assist to Provide Better Access to UK Medical Cannabis

Aurora Cannabis completes reverse share split to maintain NASDAQ listing requirements. Positive developments include five quarters of positive adjusted EBITDA, debt repayment, and guidance for positive cash flow. Focus on international medical cannabis and plant propagation business contribute to growth potential and positive cash flow.

Aurora Cannabis: Barely Surviving Or Soon To Be Thriving?

Canopy Growth

OrganiGram Holdings Inc.

Cannabis firms OrganiGram Holdings (TSX-V:OGI, NASDAQ:OGI) and Aurora Cannabis Inc (TSX:ACB, NASDAQ:ACB) are increasingly attractive on the back of encouraging quarterly financial results, analysts at Jefferies believe.  They have a ‘Buy' rating on Organigram, which they said remains a top Canadian cannabis pick, writing in a note to clients that Organigram's first quarter 2024 earnings showed progress on every metric.

Organigram and Aurora Cannabis increasingly attractive as Canopy Growth's core operations struggle: analysts

Tilray Brands

People who are involved in cannabis investing are keeping a positive outlook towards the future. Many feel this year will be big for investors and have the potential to see a rise in marijuana stocks. The start of a new year comes with many challenges and opportunities. Much of the obstacles to overcome have to do with better reform measures for legal cannabis operators. What this means is during 2024 many hope to see the end of cannabis prohibition.

3 Canadian Marijuana Stocks To Start The New Week

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

AdvisorShares Pure US Cannabis ETF

Trulieve Cannabis Corp.

Curaleaf Holdings Inc. Executive Chairman Boris Jordan and other cannabis executives on Friday praised Germany's removal of cannabis from a list of narcotics as a potential boost to the marijuana business, as stocks in the sector rose.

Cannabis stocks rise as Germany takes ‘first big step' toward broader legalization in Europe

Aurora Cannabis and Canopy Growth shares have fallen more than 99% in just five years. Both companies have been scaling back their operations and remain unprofitable.

2 Hugely Disappointing Stocks That Turned $10,000 Into Less Than $100 in Just 5 Years

Aurora Cannabis (NASDAQ: ACB ) stock is falling 6.6% in early trading today after the company disclosed that its CFO has resigned. Also noteworthy is that its new CFO worked for many years at a very large, well-known drug maker but appears to have not held a full-time position since July 2023.

ACB Stock Alert: What Is Going on With Aurora Cannabis Shares Today?

NASDAQ | TSX: ACB EDMONTON, AB , Feb. 20, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, is pleased to announce today that Simona King, a former executive of Bristol Myers-Squibb, a leading multinational pharmaceutical company, has been appointed as Chief Financial Officer of the Company, effective February 21, 2024. Ms. King brings over 25 years of progressive finance leadership experience, with deep business knowledge and proven success with global and emerging organizations.

Aurora Cannabis Announces CFO Transition and Completion of Previously Announced Share Consolidation

Onion Global Ltd

Investors are working on various strategies to see returns from their marijuana stock investments. As most who are active in the sector can see the upward momentum is not consistent. Much of the way cannabis stocks perform is based on volatility and other catalysts. For example, when there is news important enough to interest traders it often leads to a rise in trading. Still with a lot going on throughout the cannabis sector where is one to start when developing a trading plan?

Cannabis Investing: Are Big Gains Coming For These Marijuana Stocks?

MedMen Enterprises Inc.

Recent developments underscore the turbulent scenario investors are grappling with in the cannabis sphere, shedding light on the cannabis stocks to sell. While the U.S Drug Enforcement Administration mulls over changing marijuana's Schedule 1 status and the Health and Human Services leans towards relaxing federal restrictions, a sliver of hope emerges.

Exit Now! 3 Cannabis Stocks to Sell in February 2024

Peloton

Aurora Cannabis has plenty of company-specific problems made worse by the challenging state of its industry. Peloton's pandemic tailwind is over, and the business is now struggling under the weight of stiff competition.

2 Stocks to Avoid in 2024 and Beyond

In February 2024, top Canadian cannabis stocks showed mixed performance amid evolving market dynamics. Companies like Canopy Growth, Aurora Cannabis, and Tilray Brands remained focal points for investors. Market movements were influenced by quarterly earnings reports, with some companies exceeding expectations and others falling short. This period saw significant attention to operational efficiencies and international expansion efforts. Additionally, updates on product innovation and strategic partnerships were crucial. Investors closely monitored these developments, leveraging technical analysis to identify potential entry and exit points.

Leading Canadian Cannabis Stock Powers Through with Strong Weekly Momentum

Aurora Cannabis Inc. (ACB) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to loss of $0.14 per share a year ago.

Aurora Cannabis Inc. (ACB) Reports Q3 Loss, Tops Revenue Estimates

Aurora Cannabis Inc. (ACB) Q3 2024 Earnings Call Transcript

Aurora Cannabis (NASDAQ: ACB ) stock is climbing higher on Thursday after completing its acquisition of MedReleaf Australia. Aurora Cannabis used a wholly-owned subsidiary to acquire the 90% stake in MedReleaf Australia that it didn't already own.

ACB Stock Alert: The $50 Million Reason Aurora Cannabis Is Up Today

Aurora Cannabis Inc (TSX:ACB, NASDAQ:ACB) shares moved higher in early trade on Thursday after the Alberta-based medical cannabis firm reaffirmed that it is on track to achieve positive free cash flow by the end of the 2024 calendar year along with fiscal third quarter financial results that demonstrated the strength of its medical cannabis segment.  The company also announced that it will become the largest global medical cannabis company operating in nationally legal markets following its acquisition of MedReleaf Australia, the company's strategic partner since 2017 that holds the number two position in Australia's medical marijuana market.

Aurora Cannabis still sees positive free cash flow by year-end as it expands medical cannabis business

Aurora Cannabis Inc (NASDAQ: ACB) is in focus today after buying the remaining 90% stake in MedReleaf Australia for about AU$50 million ($32.45 million). Details of Aurora-MedReleaf transaction The licensed cannabis producer paid $9.45 million in cash and the remaining in stock.

Aurora Cannabis just bought MedReleaf Australia: find out more

NASDAQ | TSX: ACB Re-Affirms Commitment to Achieving Positive Free Cash Flow 1  This Calendar Year, Delivers Fifth Consecutive Quarter of Positive Adjusted EBITDA 1 Aurora Becomes the Largest Global Medical Cannabis Company in Nationally Legal Markets Following the Acquisition of MedReleaf Australia Strong YoY Growth of 41% in High Margin International Net Cannabis Revenue 1 Cash position of over $200 Million as of Quarter Close, Remaining Convertible Debt of $7.3 Million to be Fully Repaid in February EDMONTON, AB , Feb. 8, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canada-based leading global medical cannabis company, today announced its financial and operational results for the third quarter of fiscal year 2024. As the fiscal year 2023 consisted of three quarters, the year-over-year comparison quarter for Q3 2024 ending December 31, 2023, is Q2 2023 ending December 31, 2022.

Aurora Cannabis Announces Fiscal 2024 Third Quarter Results; Generates Record Adjusted EBITDA of $4.3 Million

NASDAQ | TSX: ACB Aurora becomes the largest global medical cannabis company operating in nationally legal markets. MedReleaf Australia holds the #2 position in medical cannabis within the rapidly growing ~AUD$400 million1 Australian market.

Aurora Cannabis Acquires MedReleaf Australia

Cannabis stocks have not been in the market's favor for a while. Green Thumb Industries is working to efficiently exploit new markets.

Which Pot Stock Will Climb in 2024: Green Thumb Industries vs. Aurora Cannabis

NASDAQ | TSX: ACB Re-affirms expectation of positive annual Adjusted EBITDA1 for fiscal 2024 and Positive Free Cash Flow1 generation in calendar 2024 Announces Intention to Consolidate Common Shares Q3 2024 Investor Conference call scheduled for February 8, 2024 at 8:00 a.m. Eastern Time EDMONTON, AB , Jan. 31, 2024 /PRNewswire/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, provided key business updates today and confirmed that it will release financial results and host an investor conference call for its third quarter of fiscal 2024 ended December 31, 2023, on February 8, 2024.

Aurora Cannabis Provides Business Update and Announces Date of Third Quarter Fiscal Year 2024 Investor Conference Call

Cronos Group

GrowGeneration Corp

SNDL Inc.

Given recent news items regarding the federal legalization of cannabis, you may think now is the time to be thinking about which cannabis stocks to buy, not which cannabis stocks to sell. Yes, the release of a letter from the U.S. Department of Health and Human Services, recommending that marijuana be rescheduled as a Schedule III drug, may be seen as signs of marijuana legalization progress.

7 Cannabis Stocks to Sell as the Industry Faces Legal Uncertainty in 2024

NASDAQ | TSX: ACB  Available at launch exclusively to Aurora's veteran patients, new products span THC, CBD and CBG offerings to meet the discerning taste, experience and product variety patients seek EDMONTON, AB , Jan. 24, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces the launch of three new cannabis-infused beverages, available exclusively at first to veteran patients. Designed to deliver on taste, potency and choice, the introduction of beverages is in response to the needs of patients looking for alternative forms of cannabis to support their wellbeing.

Aurora Unveils Innovative Cannabis-Infused Ready-to-Drink Beverage in Latest Medical Product Launch

Cannabis ETFs are garnering attention in 2024 as the industry shows promising growth. Key players like MJ, MSOS, and CNBS dominate this sector. These ETFs offer diversified exposure to cannabis-related stocks. This includes companies involved in cultivation, production, and retail. The U.S. cannabis industry has seen remarkable growth. Statistics reveal a projected market size of over $30 billion by 2025. This growth is fueled by expanding legalization and increased consumer acceptance. Investors are increasingly attracted to this sector for its high-growth potential. However, the industry faces regulatory challenges and market volatility.

News for Aurora Cannabis Stock (ACB)